Zobrazeno 1 - 10
of 2 993
pro vyhledávání: '"Abreu, N"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rebillard E; Médecine Digestive et Hépato-Biliaire, Centre Hospitalier Universitaire de Clermont-Ferrand, 1 Place Lucie et Raymond Aubrac, 63003, Clermont-Ferrand Cedex 1, France., De Abreu N; Radiologie, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France., Buchard B; Médecine Digestive et Hépato-Biliaire, Centre Hospitalier Universitaire de Clermont-Ferrand, 1 Place Lucie et Raymond Aubrac, 63003, Clermont-Ferrand Cedex 1, France., Muti L; Médecine Digestive et Hépato-Biliaire, Centre Hospitalier Universitaire de Clermont-Ferrand, 1 Place Lucie et Raymond Aubrac, 63003, Clermont-Ferrand Cedex 1, France., Boulin M; Pharmacie, Centre Hospitalier Universitaire de Dijon, Dijon, France., Pereira B; Direction de la Recherche Clinique et Innovation, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France., Magnin B; Radiologie, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France., Abergel A; Médecine Digestive et Hépato-Biliaire, Centre Hospitalier Universitaire de Clermont-Ferrand, 1 Place Lucie et Raymond Aubrac, 63003, Clermont-Ferrand Cedex 1, France. aabergel@chu-clermontferrand.fr.; Radiologie, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France. aabergel@chu-clermontferrand.fr.; Pharmacie, Centre Hospitalier Universitaire de Dijon, Dijon, France. aabergel@chu-clermontferrand.fr.; Direction de la Recherche Clinique et Innovation, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France. aabergel@chu-clermontferrand.fr.; Université Clermont Auvergne, CHU, CNRS, Clermont Auvergne INP, Institut Pascal, 63000, Clermont-Ferrand, France. aabergel@chu-clermontferrand.fr.
Publikováno v:
Digestive diseases and sciences [Dig Dis Sci] 2024 Nov; Vol. 69 (11), pp. 4259-4267. Date of Electronic Publication: 2024 Sep 25.
Autor:
de-Pablo-Gómez-de-Liaño, L., Fernández-Vigo, J.I., Ventura-Abreu, N., Benito-Pascual, B., Narváez-Palazón, C., Gómez-de-Liaño, R.
Publikováno v:
In Archivos de la Sociedad Española de Oftalmología (English Ed) August 2018 93(8):392-397
Autor:
Burgos-Blasco, B. *, Ventura-Abreu, N., Jimenez-Santos, M., Narvaez-Palazon, C., Saenz-Francés, F., Santos-Bueso, E.
Publikováno v:
In Journal Français d'Ophtalmologie December 2020 43(10):1039-1046
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
CERN Yellow Report CERN-2014-004, pp.127-131
To compensate the large beam-beam tune spread and beam-beam resonance driving terms in the polarized proton operation in the Relativistic Heavy Ion Collider (RHIC), we will introduce a low-energy DC electron beam into each ring to collide head-on wit
Externí odkaz:
http://arxiv.org/abs/1410.5586
Autor:
Polacco BJ; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA., Lobingier BT; Department of Chemical Physiology and Biochemistry, Oregon Health and Sciences University, Portland, OR, USA., Blythe EE; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA., Abreu N; Department of Biochemistry, Weill Cornell Medicine, New York, NY, USA., Khare P; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA., Howard MK; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; TETRAD Graduate Program, University of California San Francisco, San Francisco, CA, USA., Gonzalez-Hernandez AJ; Department of Biochemistry, Weill Cornell Medicine, New York, NY, USA., Xu J; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA., Li Q; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA., Novy B; Department of Chemical Physiology and Biochemistry, Oregon Health and Sciences University, Portland, OR, USA., Naing ZZC; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA., Shoichet BK; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA., Coyote-Maestas W; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Levitz J; Department of Biochemistry, Weill Cornell Medicine, New York, NY, USA., Krogan NJ; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA., Von Zastrow M; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA. mark.vonzastrow@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA. mark.vonzastrow@ucsf.edu.; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA. mark.vonzastrow@ucsf.edu., Hüttenhain R; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, USA. ruthh@stanford.edu.; J. David Gladstone Institutes, San Francisco, CA, USA. ruthh@stanford.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA. ruthh@stanford.edu.; Department of Molecular and Cellular Physiology, Stanford University, Stanford, CA, USA. ruthh@stanford.edu.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2024 Sep; Vol. 20 (9), pp. 1133-1143. Date of Electronic Publication: 2024 Mar 25.
Autor:
Strauss A; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA.; Tri-Institutional Program in Chemical Biology, New York, NY, 10065, USA., Gonzalez-Hernandez AJ; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Lee J; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Abreu N; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Selvakumar P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, 10065, USA., Salas-Estrada L; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Kristt M; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Arefin A; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Huynh K; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Marx DC; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Gilliland K; Warren Center for Neuroscience Drug Discovery at Vanderbilt University, Vanderbilt University, Nashville, TN, 37232, USA., Melancon BJ; Warren Center for Neuroscience Drug Discovery at Vanderbilt University, Vanderbilt University, Nashville, TN, 37232, USA.; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA., Filizola M; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Meyerson J; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, 10065, USA., Levitz J; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA. jtl2003@med.cornell.edu.; Tri-Institutional Program in Chemical Biology, New York, NY, 10065, USA. jtl2003@med.cornell.edu.; Department of Psychiatry, Weill Cornell Medicine, New York, NY, 10065, USA. jtl2003@med.cornell.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 01; Vol. 15 (1), pp. 6498. Date of Electronic Publication: 2024 Aug 01.
Autor:
de-Pablo-Gómez-de-Liaño, L., Fernández-Vigo, J.I., Ventura-Abreu, N., Morales-Fernández, L., García-Feijóo, J., Gómez-de-Liaño, R.
Publikováno v:
In Archivos de la Sociedad Española de Oftalmología (English Ed) December 2016 91(12):567-572
Publikováno v:
Phys.Rev.ST Accel.Beams 9:1433,2006
In the Brazilian synchrotron light source, we observed that modulating the phase of the accelerating fields at approximately twice the synchrotron frequency suppressed remarkably well a longitudinal coupled-bunch mode of the beam driven by a higher o
Externí odkaz:
http://arxiv.org/abs/physics/0610083